Showing 201 - 220 results of 3,158 for search 'Patient Number 9', query time: 0.08s Refine Results
  1. 201
  2. 202

    Efficacy and Safety of Endoscopic Esophageal Dilatation in Pediatric Patients with Esophageal Strictures by Hasan M. A. Isa, Khadija A. Hasan, Husain Y. Ahmed, Afaf M. Mohamed

    Published 2021-01-01
    “…The median number of dilatation sessions per patient was three (interquartile range=2–5). …”
    Get full text
    Article
  3. 203
  4. 204
  5. 205

    Effect of antioxidant capsule supplementation on oxidative stress markers in hypertensive patients by Novaes-Gaeta Ludmila N., Moraes Mariele C., Katayama Keyla Y., Sangaletti Carine T., Irigoyen Maria Claudia, Freitas Sarah, Viana Ariane, de Angelis Katia, Caldini Elia G., Lopes Heno F.

    Published 2024-01-01
    “…Conclusion: The study results suggest that supplementation with fruit capsules rich in antioxidants for 4 weeks significantly reduces oxidative stress in hypertensive patients. Studies with a larger number of patients are needed to confirm the findings.…”
    Get full text
    Article
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211

    Proposal for a predictive scale of cognitive impairment in adult patients with neurocysticercosis by Jorge Luis Anaya González, Francisco López-Muñoz, Erlen Carmona Alvarez-Builla, Adriana Edit Miniet Castillo, Laudelina Moreira Tusell

    Published 2022-07-01
    “…The prognostic performance of each of the variables was determined by means of sensitivity, specificity, and positive and negative predictive values, with their respective 9 5% confidence intervals.<br /><strong>Results</strong>: a scale with a dichotomous format was developed, which included 7 factors (4 clinical and 3 tomographic), with which a score of 0 to 7 points was obtained for the prediction of cognitive impairment in adult patients with neurocysticercosis, with a probability of: 0-1 point: 75.3 %; 2-3 points: 95 %; ≥ 4 points: 96 %.…”
    Get full text
    Article
  12. 212

    MANAGEMENT OF MARGINAL ULCERS IN OBESE PATIENTS AFTER LAPAROSCOPIC GASTRIC BYPASS by Olexander Ioffe, Victor Nevmerzhytskyi

    Published 2023-12-01
    “…Modification of the management of obese patients after laparoscopic gastric bypass in the volume - the use of a regimen for the prevention of marginal ulcers: a proton pump inhibitor II generation 20 mg twice a day for 6 months, contributed to a decrease in the number of marginal ulcers.…”
    Get full text
    Article
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220

    Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications by David A. Close, Paul A. Johnston

    Published 2025-01-01
    “…Patient derived tumor organoid (PDTO) models retain the structural, morphological, genetic, and clonal heterogeneity of the original tumors. …”
    Get full text
    Article